Search Results - "Okada-Rising S"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies.

    Authors: Wang P Okada-Rising S Scultetus AH et al.

    Source: Biomedicines [Biomedicines] 2024 Nov 26; Vol. 12 (12). Date of Electronic Publication: 2024 Nov 26.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    From Traumatic Brain Injury to Alzheimer's Disease: Multilevel Biomechanical, Neurovascular, and Molecular Mechanisms with Emerging Therapeutic Directions.

    Authors: Katramadou, Aikaterini Bender, Eva Sonja Kanakis, Dimitrios

    Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1570. 41p.

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration.

    Authors: Giarratana AO; Nuclear Medicine and Molecular Imaging Section, Department of Radiology, University of Wisconsin-Madison, Madison, WI, United States.

    Source: Frontiers in neurology [Front Neurol] 2025 Aug 05; Vol. 16, pp. 1637243. Date of Electronic Publication: 2025 Aug 05 (Print Publication: 2025).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Brain injury biomarkers as targets for drugs development and personalized treatment for traumatic brain injury patients.

    Authors: Sandler M Almohaish S Brophy GM

    Source: Frontiers in pharmacology [Front Pharmacol] 2025 May 26; Vol. 16, pp. 1606174. Date of Electronic Publication: 2025 May 26 (Print Publication: 2025).

    Publication Type: Journal Article; Review

    Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    Amantadine Attenuates Secondary Oxidative and Inflammatory Injury by Modulating the HIF-1α/BNIP3L/HMGB1 Axis in Rat Model of Traumatic Brain Injury.

    Authors: Bindal A Karabacak P Asci H et al.

    Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Feb 11; Vol. 62 (2). Date of Electronic Publication: 2026 Feb 11.

    Publication Type: Journal Article

    Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  6. 6

    Tissue-type Differences in Focused Ultrasound and Microbubble-mediated Drug Delivery to the Brain Exist at Vessel Level.

    Authors: De Maio A Lin FH Stefanovic B et al.

    Source: Theranostics [Theranostics] 2026 Jan 01; Vol. 16 (4), pp. 1975-1996. Date of Electronic Publication: 2026 Jan 01 (Print Publication: 2026).

    Publication Type: Journal Article

    Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

    PDF Full Text
    Save to List

Search Tools: